department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

DEXMEDETOMIDINE HYDROCHLORIDE · pharmadog

pharmadog
drugs
DEXMEDETOMIDINE HYDROCHLORIDE

drug

patient view →

DEXMEDETOMIDINE HYDROCHLORIDE

Marketedupdated 2mo ago

by HQ Speciality Pharma

Approved

community read0 votes

all catalysts(10)

approval · 10

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval

DEXMEDETOMIDINE HYDROCHLORIDE

view all 10 catalysts →

News(0)

no news has mentioned this drug yet

brand

DEXMEDETOMIDINE HYDROCHLORIDE

generic

DEXMEDETOMIDINE HYDROCHLORIDE

indication

Sedation

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 4, 2032

~5.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (42)

Apr 20, 2036formulationUS 9649296
Apr 20, 2036formulationUS 9649296
Apr 20, 2036formulationUS 9717796
Apr 20, 2036formulationUS 9717796
Jul 4, 2032patentUS 8242158*PED
Jul 4, 2032patentUS 8242158*PED
Jul 4, 2032patentUS 8242158*PED
Jul 4, 2032patentUS 8338470*PED
Jul 4, 2032patentUS 8338470*PED
Jul 4, 2032patentUS 8338470*PED
Jul 4, 2032patentUS 8455527*PED
Jul 4, 2032patentUS 8455527*PED
Jul 4, 2032patentUS 8455527*PED
Jul 4, 2032patentUS 8648106*PED
Jul 4, 2032patentUS 8648106*PED
Jul 4, 2032patentUS 8648106*PED
Jul 4, 2032patentUS 9320712*PED
Jul 4, 2032patentUS 9320712*PED
Jul 4, 2032patentUS 9320712*PED
Jul 4, 2032patentUS 9616049*PED
Jul 4, 2032patentUS 9616049*PED
Jul 4, 2032patentUS 9616049*PED
Jan 4, 2032formulationUS 10016396
Jan 4, 2032formulationUS 10016396
Jan 4, 2032formulationUS 8242158
Jan 4, 2032formulationUS 8242158
Jan 4, 2032formulationUS 8242158
Jan 4, 2032formulationUS 8338470
Jan 4, 2032formulationUS 8338470
Jan 4, 2032formulationUS 8338470
Jan 4, 2032method-of-use (U-421)US 8455527
Jan 4, 2032method-of-use (U-421)US 8455527
Jan 4, 2032method-of-use (U-421)US 8455527
Jan 4, 2032formulationUS 8648106
Jan 4, 2032formulationUS 8648106
Jan 4, 2032formulationUS 8648106
Jan 4, 2032formulationUS 9320712
Jan 4, 2032formulationUS 9320712
Jan 4, 2032formulationUS 9320712
Jan 4, 2032formulationUS 9616049
Jan 4, 2032formulationUS 9616049
Jan 4, 2032formulationUS 9616049

Data sources

openFDA · ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 8

tagApproval28 co-mentions · 14 sources
drugdexmedetomidine22 co-mentions · 19 sources
drugIGALMI22 co-mentions · 19 sources
tagDrug Shortage5 co-mentions · 5 sources
companyBaxter Healthcare Corp1 co-mentions · 1 sources
company$PFEPFIZER INC1 co-mentions · 1 sources
companyMylan Institutional Inc1 co-mentions · 1 sources
companyAccord Healthcare Inc1 co-mentions · 1 sources

Trials studying DEXMEDETOMIDINE HYDROCHLORIDE

phase2The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in Childrenrecruitingn=64
—A Study to Learn About the Study Medicine - Precedex in Children From Japan.completedn=111
—Precedex Special Investigation (in Pediatric Patients)completedn=111